Matches in Wikidata for { <http://www.wikidata.org/entity/Q65379776> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q65379776 description "clinical trial" @default.
- Q65379776 description "ensayu clínicu" @default.
- Q65379776 description "klinisch onderzoek" @default.
- Q65379776 description "клінічне випробування" @default.
- Q65379776 name "A 12-week Study of Pramipexole Extended Release (ER) in Patients With Parkinson's Disease (PD), Followed by a 52-week Long-term Treatment Period" @default.
- Q65379776 name "A 12-week Study of Pramipexole Extended Release (ER) in Patients With Parkinson's Disease (PD), Followed by a 52-week Long-term Treatment Period" @default.
- Q65379776 type Item @default.
- Q65379776 label "A 12-week Study of Pramipexole Extended Release (ER) in Patients With Parkinson's Disease (PD), Followed by a 52-week Long-term Treatment Period" @default.
- Q65379776 label "A 12-week Study of Pramipexole Extended Release (ER) in Patients With Parkinson's Disease (PD), Followed by a 52-week Long-term Treatment Period" @default.
- Q65379776 prefLabel "A 12-week Study of Pramipexole Extended Release (ER) in Patients With Parkinson's Disease (PD), Followed by a 52-week Long-term Treatment Period" @default.
- Q65379776 prefLabel "A 12-week Study of Pramipexole Extended Release (ER) in Patients With Parkinson's Disease (PD), Followed by a 52-week Long-term Treatment Period" @default.
- Q65379776 P1050 Q65379776-9E67327A-0A16-4CAA-971F-8DD999FA7CDD @default.
- Q65379776 P1132 Q65379776-332CEB22-409E-4704-B35D-DB1179A264E3 @default.
- Q65379776 P1476 Q65379776-88FFDA11-BAE9-4FC0-819B-B76EC7F61063 @default.
- Q65379776 P17 Q65379776-00613E73-9679-49A6-AFF0-6DCA54FEA4EA @default.
- Q65379776 P3098 Q65379776-8CE4DC31-42A3-4702-8C22-4C15C5B772EC @default.
- Q65379776 P31 Q65379776-39BC5E31-A010-45E5-B374-E139C5C5D9FF @default.
- Q65379776 P4844 Q65379776-E3232862-124A-41FD-BFA1-AF83C0DC52CD @default.
- Q65379776 P580 Q65379776-935B351A-92BF-4753-8176-76204A0E0908 @default.
- Q65379776 P582 Q65379776-E3A3D38A-EDD4-4D9B-9FEF-D529DCD21E00 @default.
- Q65379776 P6099 Q65379776-5AD329F9-8D86-44DA-BCDA-C587E9A90121 @default.
- Q65379776 P6099 Q65379776-AA616EB5-9E89-4517-A709-7412A22C71CD @default.
- Q65379776 P8363 Q65379776-3D63DBC9-E86B-4CEC-9720-050B9237AFA1 @default.
- Q65379776 P1050 Q11085 @default.
- Q65379776 P1132 "+112" @default.
- Q65379776 P1476 "A Double-blind, Double-dummy, Randomised, Parallel-group Study to Investigate the Safety, Tolerability, Trough Plasma Concentration, and Efficacy of Pramipexole ER Versus Pramipexole Immediate Release (IR) Administered Orally for 12 Weeks in Patients With Parkinson's Disease (PD) on L-dopa Therapy, Followed by a 52-week Open-label Long-term Treatment Period to Evaluate the Long-term Safety and Efficacy of Pramipexole ER" @default.
- Q65379776 P17 Q17 @default.
- Q65379776 P3098 "NCT00560508" @default.
- Q65379776 P31 Q30612 @default.
- Q65379776 P4844 Q421304 @default.
- Q65379776 P580 "2007-11-01T00:00:00Z" @default.
- Q65379776 P582 "2009-11-01T00:00:00Z" @default.
- Q65379776 P6099 Q42824440 @default.
- Q65379776 P6099 Q42824827 @default.
- Q65379776 P8363 Q78089383 @default.